Concepedia

Publication | Open Access

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

66

Citations

32

References

2021

Year

References

YearCitations

Page 1